Vanderbilt University Medical Center: Diabetes Drug May Improve Asthma
February 22, 2023
February 22, 2023
NASHVILLE, Tennessee, Feb. 22 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Type 2 diabetes mellitus and obesity are associated with many comorbidities, including asthma. Glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs, which have been approved for the treatment of Type 2 diabetes, also may reduce asthma risk, although the mechanisms remain undefined.
New research conducted by Katherine Cahill, MD, and colleagues at VUMC and Brigh . . .
Type 2 diabetes mellitus and obesity are associated with many comorbidities, including asthma. Glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs, which have been approved for the treatment of Type 2 diabetes, also may reduce asthma risk, although the mechanisms remain undefined.
New research conducted by Katherine Cahill, MD, and colleagues at VUMC and Brigh . . .